Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancers

Mark Yarchoan, Leslie Cope, Amanda N. Ruggieri, Robert A. Anders, Anne M. Noonan, Laura W. Goff, Lipika Goyal, Jill Lacy, Daneng Li, Anuj K. Patel, Aiwu R. He, Ghassan K. Abou-Alfa, Kristen Spencer, Edward J. Kim, S. Lindsey Davis, Autumn J. McRee, Paul R. Kunk, Subir Goyal, Yuan Liu, Lauren Dennison, Stephanie Xavier, Aditya A. Mohan, Qingfeng Zhu, Andrea Wang-Gillam, Andrew Poklepovic, Helen X. Chen, Elad Sharon, Gregory B. Lesinski, Nilofer S. Azad

Open source

DOI
10.1172/jci152670
Published
2021-12-15
Container
Journal of Clinical Investigation
Publisher
American Society for Clinical Investigation
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1172/jci152670,
  title = {Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancers},
  author = {Mark Yarchoan and Leslie Cope and Amanda N. Ruggieri and Robert A. Anders and Anne M. Noonan and Laura W. Goff and Lipika Goyal and Jill Lacy and Daneng Li and Anuj K. Patel and Aiwu R. He and Ghassan K. Abou-Alfa and Kristen Spencer and Edward J. Kim and S. Lindsey Davis and Autumn J. McRee and Paul R. Kunk and Subir Goyal and Yuan Liu and Lauren Dennison and Stephanie Xavier and Aditya A. Mohan and Qingfeng Zhu and Andrea Wang-Gillam and Andrew Poklepovic and Helen X. Chen and Elad Sharon and Gregory B. Lesinski and Nilofer S. Azad},
  year = {2021},
  journal = {Journal of Clinical Investigation},
  doi = {10.1172/jci152670},
  url = {https://doi.org/10.1172/jci152670}
}

RIS

TY  - JOUR
TI  - Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancers
AU  - Mark Yarchoan
AU  - Leslie Cope
AU  - Amanda N. Ruggieri
AU  - Robert A. Anders
AU  - Anne M. Noonan
AU  - Laura W. Goff
AU  - Lipika Goyal
AU  - Jill Lacy
AU  - Daneng Li
AU  - Anuj K. Patel
AU  - Aiwu R. He
AU  - Ghassan K. Abou-Alfa
AU  - Kristen Spencer
AU  - Edward J. Kim
AU  - S. Lindsey Davis
AU  - Autumn J. McRee
AU  - Paul R. Kunk
AU  - Subir Goyal
AU  - Yuan Liu
AU  - Lauren Dennison
AU  - Stephanie Xavier
AU  - Aditya A. Mohan
AU  - Qingfeng Zhu
AU  - Andrea Wang-Gillam
AU  - Andrew Poklepovic
AU  - Helen X. Chen
AU  - Elad Sharon
AU  - Gregory B. Lesinski
AU  - Nilofer S. Azad
PY  - 2021
JO  - Journal of Clinical Investigation
DO  - 10.1172/jci152670
UR  - https://doi.org/10.1172/jci152670
ER  - 

APA

Yarchoan, M., Cope, L., Ruggieri, A. N., Anders, R. A., Noonan, A. M., Goff, L. W., Goyal, L., Lacy, J., Li, D., Patel, A. K., He, A. R., Abou-Alfa, G. K., Spencer, K., Kim, E. J., Davis, S. L., McRee, A. J., Kunk, P. R., Goyal, S., Liu, Y., Dennison, L., Xavier, S., Mohan, A. A., Zhu, Q., Wang-Gillam, A., Poklepovic, A., Chen, H. X., Sharon, E., Lesinski, G. B., & Azad, N. S. (2021). Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancers. Journal of Clinical Investigation. https://doi.org/10.1172/jci152670

Source records